PL2157177T3 - Sposób preparatywnego oczyszczania ludzkiej furyny - Google Patents

Sposób preparatywnego oczyszczania ludzkiej furyny

Info

Publication number
PL2157177T3
PL2157177T3 PL09013384T PL09013384T PL2157177T3 PL 2157177 T3 PL2157177 T3 PL 2157177T3 PL 09013384 T PL09013384 T PL 09013384T PL 09013384 T PL09013384 T PL 09013384T PL 2157177 T3 PL2157177 T3 PL 2157177T3
Authority
PL
Poland
Prior art keywords
purification process
preparative purification
human furin
furin
human
Prior art date
Application number
PL09013384T
Other languages
English (en)
Inventor
Peter Matthiessen
Stefan Romeder-Finger
Peter Turecek
Hans-Peter Schwarz
Original Assignee
Baxalta Inc
Baxalta GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxalta Inc, Baxalta GmbH filed Critical Baxalta Inc
Publication of PL2157177T3 publication Critical patent/PL2157177T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21075—Furin (3.4.21.75)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL09013384T 2007-05-22 2008-05-21 Sposób preparatywnego oczyszczania ludzkiej furyny PL2157177T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93130107P 2007-05-22 2007-05-22
EP08758691A EP2147097A2 (en) 2007-05-22 2008-05-21 PREPARATIVE PURIFICATION METHOD FOR HUMAN FURINE
EP09013384.4A EP2157177B1 (en) 2007-05-22 2008-05-21 Preparative purification process for human furin

Publications (1)

Publication Number Publication Date
PL2157177T3 true PL2157177T3 (pl) 2013-12-31

Family

ID=39712592

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09013384T PL2157177T3 (pl) 2007-05-22 2008-05-21 Sposób preparatywnego oczyszczania ludzkiej furyny

Country Status (13)

Country Link
US (2) US8343748B2 (pl)
EP (2) EP2157177B1 (pl)
JP (1) JP5485873B2 (pl)
KR (1) KR101660533B1 (pl)
AU (1) AU2008253230B2 (pl)
CA (1) CA2684885C (pl)
DK (1) DK2157177T3 (pl)
ES (1) ES2416079T3 (pl)
HR (1) HRP20130560T1 (pl)
PL (1) PL2157177T3 (pl)
PT (1) PT2157177E (pl)
SI (1) SI2157177T1 (pl)
WO (1) WO2008141824A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2574677T1 (sl) 2007-12-27 2017-11-30 Baxalta GmbH Procesi celične kulture
SG192471A1 (en) * 2007-12-31 2013-08-30 Baxter Int Substantially animal protein-free recombinant furin and methods for producing same
WO2012059495A1 (en) * 2010-11-05 2012-05-10 F. Hoffmann-La Roche Ag Optimized method for antibody capturing by mixed mode chromatography
RU2610436C2 (ru) 2011-06-02 2017-02-10 Баксалта Инкорпорейтед Составы рекомбинантного фурина
JP6292718B2 (ja) 2011-07-01 2018-03-14 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 凝集ポリペプチドから単量体ポリペプチドを分離するための方法
KR20230107621A (ko) * 2020-11-13 2023-07-17 아이코사백스, 인크. 메타뉴모바이러스에 대한 단백질-기반 나노입자 백신

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9000917A (nl) 1989-10-25 1991-05-16 Holland Biotechnology Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten.
US5935815A (en) 1989-10-25 1999-08-10 Katholieke Universiteit Leuven Process for micro biological production of proteins
EP0785273A1 (en) 1990-11-26 1997-07-23 Genetics Institute, Inc. Paired basic amino acid converting enzyme and DNA sequence encoding it
AT404838B (de) * 1995-11-24 1999-03-25 Immuno Ag Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
AT410216B (de) 1999-08-10 2003-03-25 Baxter Ag Faktor x-analogon mit verbesserter aktivierbarkeit
SG192471A1 (en) * 2007-12-31 2013-08-30 Baxter Int Substantially animal protein-free recombinant furin and methods for producing same

Also Published As

Publication number Publication date
HK1145188A1 (en) 2011-04-08
US20130115204A1 (en) 2013-05-09
KR101660533B1 (ko) 2016-10-10
DK2157177T3 (da) 2013-06-24
AU2008253230A1 (en) 2008-11-27
HRP20130560T1 (hr) 2013-07-31
EP2157177A1 (en) 2010-02-24
US8343748B2 (en) 2013-01-01
WO2008141824A3 (en) 2009-03-12
JP2010527596A (ja) 2010-08-19
CA2684885A1 (en) 2008-11-27
AU2008253230B2 (en) 2013-07-18
ES2416079T3 (es) 2013-07-30
SI2157177T1 (sl) 2013-05-31
US20090304669A1 (en) 2009-12-10
CA2684885C (en) 2018-09-11
KR20100022067A (ko) 2010-02-26
WO2008141824A2 (en) 2008-11-27
PT2157177E (pt) 2013-04-18
JP5485873B2 (ja) 2014-05-07
EP2157177B1 (en) 2013-04-10
EP2147097A2 (en) 2010-01-27

Similar Documents

Publication Publication Date Title
GB2465956B (en) Preparative separation/ purification system
GB2465954B (en) Preparative separation/ purification system
GB2445465B (en) Process for waste treatment
IL201388A0 (en) Immunoglobulin purification
GB2465955B (en) Preparative separation/ purification system
EP2123873A4 (en) EXHAUST PURIFICATION APPARATUS
EP2192284A4 (en) EMISSION CONTROL DEVICE
GB0706978D0 (en) Process
EP2175114A4 (en) EMISSION CONTROL DEVICE
GB2465957B (en) Preparative separation/ purification system
EP2194250A4 (en) APPARATUS FOR PURIFYING EXHAUST GAS
SG10201406061TA (en) Melt-crystallization separation and purification process
GB0808908D0 (en) Purification process
EP2467329A4 (en) CONTROL OF PROCESS FOR PURIFYING IMPROVED METALLURGICAL SILICON MATERIAL (SI-UMG)
EP2101901A4 (en) SEPARATION PROCESS
HRP20130560T1 (hr) Pripravni postupak proäśišä†avanja ljudskog furina
GB0700074D0 (en) process
EP2144854A4 (en) WASTE MANAGEMENT SYSTEM
GB0818924D0 (en) Water purification apparatus
GB0700878D0 (en) Process
GB0818228D0 (en) Purification process
ZA200806049B (en) Cefdinir synthesis process
EP2383099A4 (en) CYLINDRICAL BACK WASH CLEANING DEVICE
GB0709689D0 (en) Process
GB0811505D0 (en) Purification process